Shattuck Labs, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.0M | $5.7M | $1.7M | $652,000 | $30.0M |
| Research and development | $35.3M | $67.2M | $74.3M | $82.9M | $56.6M |
| Operating expenses | $52.5M | $86.3M | $93.6M | $104.0M | $75.3M |
| Operating income | -$51.5M | -$80.6M | -$92.0M | -$103.3M | -$45.3M |
| Income tax expense | $0 | $0 | $0 | $0 | $0 |
| Net income | -$48.8M | -$75.4M | -$87.3M | -$101.9M | -$45.0M |
| Balance Sheet | |||||
| Cash and equivalents | $54.2M | $57.4M | $125.6M | $47.4M | $92.3M |
| Current assets | $82.5M | $79.2M | $143.2M | $184.6M | $288.3M |
| Total assets | $91.0M | $91.0M | $159.6M | $205.3M | $298.6M |
| Current liabilities | $7.1M | $8.9M | $11.5M | $25.0M | $24.6M |
| Total liabilities | $8.6M | $11.4M | $14.9M | $29.2M | $26.8M |
| Stockholders' equity | $82.4M | $79.6M | $144.7M | $176.2M | $271.8M |
| Cash Flow Statement | |||||
| Cash from operations | -$39.9M | -$60.5M | -$81.2M | -$94.5M | -$57.1M |
| Depreciation and amortization | $3.7M | $3.8M | $4.0M | $3.1M | $1.4M |
| Stock-based compensation | $7.0M | $9.5M | $6.9M | $6.5M | $5.5M |
| Capital expenditure | $71,000 | $59,000 | $407,000 | $11.6M | $7.9M |
| Free cash flow | -$40.0M | -$60.6M | -$81.6M | -$106.1M | -$65.0M |
| Impairments | — | $222,000 | $303,000 | $700,000 | $0 |
Shares outstanding 76.7M · Free float 64.7%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.